Milestone Scientific (NYSE:MLSS) Stock Price Down 2.3% – Here’s Why

Milestone Scientific Inc. (NYSE:MLSS)’s stock price was down 2.3% during mid-day trading on Thursday . The company traded as low as $0.3650 and last traded at $0.3899. Approximately 86,852 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 1,454,839 shares. The stock had previously closed at $0.3990.

Milestone Scientific Price Performance

The company has a market capitalization of $33.73 million, a price-to-earnings ratio of -5.47 and a beta of 0.97. The stock has a fifty day simple moving average of $0.32 and a 200-day simple moving average of $0.31.

Institutional Trading of Milestone Scientific

An institutional investor recently raised its position in Milestone Scientific stock. Raymond James Financial Inc. grew its holdings in Milestone Scientific Inc. (NYSE:MLSS) by 416.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 62,000 shares of the company’s stock after buying an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned 0.08% of Milestone Scientific worth $39,000 as of its most recent SEC filing. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.